688
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Handgrip Strength Seems Not to Be Affected by COPD Disease Progression: A Longitudinal Cohort Study

ORCID Icon, , , , , , , , , & show all
Pages 150-155 | Received 15 Aug 2019, Accepted 04 Feb 2020, Published online: 19 Feb 2020

References

  • Butcher SJ, Pikaluk BJ, Chura RL, et al. Associations between isokinetic muscle strength, high-level functional performance, and physiological parameters in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2012;7:537–542. [Database] doi:10.2147/COPD.S34170.
  • McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015;2:Cd003793.
  • Maltais F, Decramer M, Casaburi R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15–62. doi:10.1164/rccm.201402-0373ST.
  • Puhan MA, Siebeling L, Zoller M, et al. Simple functional performance tests and mortality in COPD. Eur Respir J. 2013;42(4):956–963. doi:10.1183/09031936.00131612.
  • Burtin C, Ter Riet G, Puhan MA, et al. Handgrip weakness and mortality risk in COPD: a multicentre analysis. Thorax 2016;71(1):86–87. doi:10.1136/thoraxjnl-2015-207451.
  • Felipe C, Bartolome C, Miguel D, et al. Longitudinal changes in handgrip strength, hyperinflation, and 6-minute walk distance in patients with COPD and a control group. Chest 2015;148(4):986–994. doi:10.1378/chest.14-2878.
  • Jeong M, Kang HK, Song P, et al. Hand grip strength in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017;12:2385–2390. doi:10.2147/COPD.S140915.
  • Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa021322.
  • Vaidya T, Chambellan A, de Bisschop C. Sit-to-stand tests for COPD: a literature review. Respir Med. 2017;128:70–77. doi:10.1016/j.rmed.2017.05.003.
  • Crook S, Frei A, Ter Riet G, et al. Prediction of long-term clinical outcomes using simple functional exercise performance tests in patients with COPD: a 5-year prospective cohort study. Respir Res. 2017;18(1):112. doi:10.1186/s12931-017-0598-6.
  • Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet 2015;386(9990):266–273. doi:10.1016/S0140-6736(14)62000-6.
  • Vaidya T, Beaumont M, de Bisschop C, et al. Determining the minimally important difference in quadriceps strength in individuals with COPD using a fixed dynamometer. Int J Chron Obstruct Pulmon Dis. 2018; 13:2685–2693. doi:10.2147/COPD.S161342.
  • Lopez-Lopez L, Torres-Sanchez I, Romero-Fernandez R, et al. Impact of previous physical activity levels on symptomatology, functionality, and strength during an acute exacerbation in COPD patients. Healthcare (Basel) 2018;6(4):139.
  • Xavier RF, Pereira A, Lopes AC, et al. Identification of phenotypes in people with copd: influence of physical activity, sedentary behaviour, body composition and skeletal muscle strength. Lung 2018;197:37–45. doi:10.1007/s00408-018-0177-8.
  • Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2018. Report). 2018.
  • Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40(4):423–429. doi:10.1093/ageing/afr051.
  • Bohannon RW. Minimal clinically important difference for grip strength: a systematic review. J Phys Ther Sci. 2019;31(1):75–78. doi:10.1589/jpts.31.75.
  • Spruit MA, Sillen MJH, Groenen MTJ, et al. New normative values for handgrip strength: results from the UK Biobank. J Am Med Dir Assoc. 2013;14(10):775.e5–775.e11. doi:10.1016/j.jamda.2013.06.013.
  • A. T. S. Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111–117.
  • Crook S, Busching G, Schultz K, et al. A multicentre validation of the 1-min sit-to-stand test in patients with COPD. Eur Respir J. 2017;49(3):1601871. doi:10.1183/13993003.01871-2016.
  • Radtke T, Hebestreit H, Puhan MA, et al. The 1-min sit-to-stand test in cystic fibrosis - Insights into cardiorespiratory responses. J Cyst Fibros. 2017;16(6):744–751. doi:10.1016/j.jcf.2017.01.012.
  • Strassmann A, Steurer-Stey C, Lana KD, et al. Population-based reference values for the 1-min sit-to-stand test. Int J Public Health. 2013;58(6):949–953. doi:10.1007/s00038-013-0504-z.
  • Radtke T, Puhan MA, Hebestreit H, et al. The 1-min sit-to-stand test–A simple functional capacity test in cystic fibrosis?. J Cyst Fibros. 2016;15(2):223–226. doi:10.1016/j.jcf.2015.08.006.
  • Van Remoortel H, Raste Y, Louvaris Z, et al. Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One. 2012;7(6):e39198. doi:10.1371/journal.pone.0039198.
  • Watz H, Pitta F, Rochester CL, et al. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J. 2014;44(6):1521–1537. doi:10.1183/09031936.00046814.
  • Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511–522. doi:10.1183/09031936.05.00035005.
  • Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26(4):720–735. doi:10.1183/09031936.05.00034905.
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805.
  • Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509.
  • World Health Organization. International statistical classification of diseases and related health problem, 10th revision. 5th ed. Geneva: World Health Organization; 2015.
  • Sievi NA, Senn O, Brack T, et al. Impact of comorbidities on physical activity in COPD. Respirology 2015;20(3):413–418. doi:10.1111/resp.12456.
  • Donaldson AV, Maddocks M, Martolini D, et al. Muscle function in COPD: a complex interplay. Int J Chron Obstruct Pulmon Dis. 2012;7:523–535. doi:10.2147/COPD.S28247.
  • Sillanpää E, Stenroth L, Bijlsma AY, et al. Associations between muscle strength, spirometric pulmonary function and mobility in healthy older adults. AGE 2014;36(4):9667. doi:10.1007/s11357-014-9667-7.
  • Stenholm S, Rantanen T, Heliovaara M, et al. The mediating role of C-reactive protein and handgrip strength between obesity and walking limitation. J Am Geriatr Soc. 2008;56(3):462–469. doi:10.1111/j.1532-5415.2007.01567.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.